Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biospecifics Technologies Corp (NASDAQ:BSTC)

36.12
Delayed Data
As of 4:00pm ET
 -0.09 / -0.25%
Today’s Change
30.70
Today|||52-Week Range
72.07
-15.94%
Year-to-Date
New Strong Sell Stocks for May 13th
May 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close36.21
Today’s open35.97
Day’s range35.40 - 36.56
Volume41,935
Average volume (3 months)65,307
Market cap$254.2M
Dividend yield--
Data as of 4:00pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+100.00%
Earnings growth (this year)+6.06%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+61.61%
P/E ratio26.0
Price/Sales13.74
Price/Book5.59

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...+5.78+50.48%
ENZEnzo Biochem Inc+0.05+0.81%
NVIVInVivo Therapeutics ...-0.37-5.47%
RGNXRegenxbio Inc+0.01+0.08%
Data as of 4:01pm ET, 05/26/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)$0.46
Annual revenue (last year)$22.8M
Annual profit (last year)$9.6M
Net profit margin42.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Thomas L. Wegman
Controller
James Goris
Corporate headquarters
Lynbrook, New York

Forecasts

Partner Offers

Search for Jobs